R 840
Alternative Names: S 26431Latest Information Update: 29 Jun 2000
At a glance
- Originator 3M Pharmaceuticals
- Class Antiasthmatics; Benzoic acids; Bronchodilators
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 29 Jun 2000 No-Development-Reported for Asthma (Unknown route)